Wang Michael

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 124 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world treatment of patients with severe congenital protein C deficiency with protein C concentrate: A physician survey

Michael Wang, Hans-Jörg Hertfelder,Elyse Swallow, Alexandra Greatsinger,Emma Billmyer, Samson Fung,Peter L. Turecek, Hanna T. Gazda,Csaba Siffel

Thrombosis Update (2024): 100159

引用0浏览0引用

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

Bella Madan,Margareth C. Ozelo,Priyanka Raheja,Emily Symington,Doris V. Quon,Andrew D. Leavitt,Steven W. Pipe,Gillian Lowe,Gili Kenet,Mark T. Reding,Jane Mason,Michael Wang,

Journal of Thrombosis and Haemostasis (2024)

引用0浏览0WOS引用

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B

Richard Lemons,Michael Wang,Julie Curtin, Lynda Mae Lepatan,Christoph Male,Flora Peyvandi,Mario von Depka Prondzinski, Rongrong Wang, William McKeand,Wilfried Seifert,Johannes Oldenburg

TH open : companion journal to thrombosis and haemostasisno. 1 (2024): e155-e163

引用0浏览0WOS引用

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W Pipe,Frank W G Leebeek,Michael Recht,Nigel S Key,Giancarlo Castaman,Wolfgang Miesbach,Susan Lattimore,Kathelijne Peerlinck,Paul Van der Valk,Michiel Coppens,Peter Kampmann,Karina Meijer,

The New England journal of medicine（2023）

引用41浏览0WOS引用

Treatment with marstacimab for people with severe hemophilia A or B: a plain language summary

Johnny Mahlangu,José Luis Lamas,Juan Cristobal Morales, Daniel Rudolf Malan, Silva Zupančić Šalek,Michael Wang, Lisa Boggio, Inga Hegemann,Andrzej Mital, Matthew Cardinal,Tong Zhu, Pengling Sun,

Future rare diseases (2023)

引用0浏览0引用

Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial

Frank W G Leebeek,Flora Peyvandi,Andreas Tiede,Giancarlo Castaman,Miguel Escobar,Michael Wang,Bulent Zülfikar,Sophie Susen,Wolfgang Miesbach,Scarlett Wang,Yi Wang,Jingmei Zhang,

Eur J Haematol（2023）

引用0浏览0WOS引用

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

Johnny Mahlangu,Radoslaw Kaczmarek,Annette von Drygalski,Susan Shapiro,Sheng-Chieh Chou,Margareth C Ozelo,Gili Kenet,Flora Peyvandi,Michael Wang,Bella Madan,Nigel S Key, Michael Laffan,

N Engl J Med（2023）

引用32浏览0WOS引用

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

Robert F Sidonio,Paulette C Bryant,Jorge Di Paola,Sarah Hale, Meadow Heiman, G Shellye Horowitz,Christi Humphrey,Julie Jaffray,Lora C Joyner,Raj Kasthuri,Barbara A Konkle,Peter A Kouides,

Expert Rev Hematol（2023）

引用12浏览0WOS引用

PB1249 Prospective, Observational Study of the Clinical Characteristics of Adults and Adolescents with Severe Hemophilia A

P. Chowdary, L. Khoo,M. Wang,H. Chambost, A. Chan, A. Moryusef, A. Willemze,J. Oldenburg

Research and Practice in Thrombosis and Haemostasis (2023): 101141-101141

引用0浏览0引用

Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (<12 years) with Hemophilia a or B with Inhibitors

Steven Pipe,Johannes Oldenburg,Manuel Carcao,Meera Chitlur,Yesim Dargaud,Joanna Davis,Carmen Escuriola,Charles Hay,Cedric Hermans,Nina Hwang,Victor Jimenez-Yuste,Craig Kessler,

BLOODno. Supplement 1 (2023): 5480-5480

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 124 篇作者统计合作学者相似作者